Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
about
Synthesis of Biocompatible Titanate Nanofibers for Effective Delivery of Neuroprotective Agents.Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease.
P2860
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@en
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@nl
type
label
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@en
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@nl
prefLabel
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@en
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@nl
P2093
P2860
P356
P1476
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
@en
P2093
Aruna Sharma
Dafin F Muresanu
Hari S Sharma
P2860
P304
P356
10.2217/NMT-2016-0037
P577
2016-11-09T00:00:00Z